4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000013
Farrow Jeffrey S sold 14,396 shares at $60.95 ($877,436)
- Farrow Jeffrey S acquired 27,881 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 1 in the form | +27,881 | 71,197 | D | ||
| 2026-06-16 | Sale : show line 2 in the form | −14,396 | $60.95 | $877,436 | 56,801 | D |
| Open-market sales · 14,396 sh · avg $60.95 · $877,436 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −27,881 | 27,882 | D |
Loading xslF345X06/wk-form4_1781727451.xml…